EUVIMEDEUVIMED entdecken
Crossref

Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study

Zhongbo Yin, Xuedong Zhang, Xiao Sun, Yunlong Huo, Nan Ji, Keyan Chen iD

American Journal of Physiology-Cell Physiology · 2024

DOI: 10.1152/ajpcell.00684.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Zhongbo Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ubiquitin Thiolesterase, Radiation Tolerance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mogrol enhances non-small cell lung cancer (NSCLC) cell sensitivity to radiotherapy by downregulating USP22 through the ERK/CREB pathway, reducing COX2 expression. These findings highlight mogrol’s potential as an adjunct to improve NSCLC radiotherapy and open avenues for further research and clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsUbiquitin ThiolesteraseRadiation ToleranceApoptosisHumansAnimalsMiceXenograft Model Antitumor AssaysMice, NudeCyclooxygenase 2Cyclic AMP Response Element-Binding ProteinA549 CellsCell Line, TumorCell SurvivalMaleCell ProliferationGene Expression Regulation, NeoplasticFemaleRadiation-Sensitizing Agents

Stichwörter der Autor:innen

ERK/CREB pathwayUSP22mogrolnon-small cell lung cancerradiosensitivity

Substanzen

Ubiquitin ThiolesteraseUsp22 protein, humanCyclooxygenase 2Cyclic AMP Response Element-Binding ProteinPTGS2 protein, humanCREB1 protein, humanRadiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Pathology, Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong, China.
  • Master Degree Candidate, Affiliated Central Hospital of Shenyang Medical College, Shenyang, Liaoning, China.
  • Department of Pathology, Shengjing Hospital affiliated to China Medical University, Shenyang, Liaoning, China.
  • Department of Docimasiology, Baoan Central Hospital of Shenzhen, China, Shenzhen, Guangdong, China.
  • Department of Laboratory Animal Science, China Medical University, Shenyang, Liaoning, China.

ORCID-Profile: Keyan Chen

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Yin, Z., Zhang, X., Sun, X., Huo, Y., Ji, N., & Chen, K. (2024). Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00684.2023

Vancouver

Yin Z, Zhang X, Sun X, Huo Y, Ji N, Chen K. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00684.2023

BibTeX
@article{Yin2024,
  author = {Yin, Zhongbo and Zhang, Xuedong and Sun, Xiao and Huo, Yunlong and Ji, Nan and Chen, Keyan},
  title = {Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2024},
  doi = {10.1152/ajpcell.00684.2023}
}
Kostenlos starten →